Form 4: Arteris Inc. Exec Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Arteris, Inc. (AIP) reports a Form 4 filing detailing the sale of common stock by President and CEO K. Charles Janac, executed under a pre-established 10b5-1 trading plan.
Summary
- K. Charles Janac, President and CEO of Arteris, Inc. (AIP), reported a transaction on April 8, 2026.
- The transaction involved the sale of 70,000 shares of common stock at a weighted average price of $19.0398.
- These sales were conducted under a Rule 10b5-1 trading plan adopted on March 5, 2025.
- Following the transaction, Janac beneficially owns 9,119,071 shares, with 70,000 held directly and the remainder indirectly through Bayview Legacy, LLC and the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it reports a significant stock sale by a top executive, the transaction was conducted under a pre-established 10b5-1 plan, mitigating concerns about opportunistic selling based on non-public information.
Negatives
- Company insider, President and CEO K. Charles Janac, sold a significant number of shares (70,000).
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a 10b5-1 plan indicates a pre-arranged selling strategy, often employed by executives to diversify holdings or manage personal finances without triggering insider trading concerns. The specific price range and volume of shares sold can be of interest to investors monitoring insider activity.
Stakeholder Impact
- Shareholders may view the sale of shares by the CEO with scrutiny, although the use of a 10b5-1 plan suggests a planned divestment rather than a reaction to negative company performance.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 04/08/2026 | Date of the earliest transaction reported in the filing. |
| 04/10/2026 | Date the Form 4 was signed by the attorney-in-fact for the Reporting Person. |
Keywords
Arteris Inc., AIP, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, K. Charles Janac
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.